dactinomycin has been researched along with bromocriptine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Levy, A; Lightman, SL | 1 |
| Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M | 1 |
| Costello, LC; Franklin, RB; Liu, Y | 1 |
1 review(s) available for dactinomycin and bromocriptine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dactinomycin and bromocriptine
| Article | Year |
|---|---|
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine | 1986 |
4 other study(ies) available for dactinomycin and bromocriptine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Bromocriptine reduces rat thyrotropin beta-subunit mRNA stability.
Topics: Administration, Oral; Animals; Base Sequence; Blotting, Northern; Bromocriptine; Cells, Cultured; Dactinomycin; Dopamine; Gene Expression Regulation; Male; Molecular Sequence Data; Nucleic Acid Hybridization; Oligonucleotide Probes; Pituitary Gland, Anterior; Rats; Rats, Inbred Strains; RNA, Messenger; Thyrotropin; Transcription, Genetic | 1990 |
Prolactin specifically regulates citrate oxidation and m-aconitase of rat prostate epithelial cells.
Topics: Aconitate Hydratase; Animals; Blotting, Western; Bromocriptine; Citrates; Cycloheximide; Dactinomycin; Epithelial Cells; Epithelium; Hormone Antagonists; Kidney; Male; Mitochondria; Oxidation-Reduction; Prolactin; Prostate; Rats; Rats, Wistar | 1996 |